Drugs / Beraksurf
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04847375 | Apr → Jul 2021 | COVID-19, adult acute respiratory distress syndrome | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beraksurf | “The drug was provided as “Beraksurf” as 100 mg in 4 mL vials.” PMID 33176850 ↗ Nov 2020 |